Intelligent Bio Solutions INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Intelligent Bio Solutions Inc. will hold its Annual Meeting on October 16, 2025, seeking stockholder approval for director elections, auditor ratification, an increase in its long-term incentive plan shares, the issuance of shares from a warrant exercise inducement, and a potential reverse stock split.
NASDAQ
Intelligent Bio Solutions Inc. files a supplement to its proxy statement to include Inline XBRL tagging of disclosures related to insider trading and equity award policies.
NASDAQ
DEFA14A: Intelligent Bio Solutions Revises Stock Incentive Plan Following Advisory Firm Recommendation
Intelligent Bio Solutions Inc. is amending its 2019 Long Term Incentive Plan to reduce the number of shares to be added, following a recommendation against the original proposal from proxy advisory firm Glass, Lewis & Co. and feedback from stockholders.
NASDAQ
Intelligent Bio Solutions Inc. is soliciting proxies for its Annual Meeting of Stockholders to be held on May 8, 2025, including a proposal to amend its 2019 Long Term Incentive Plan.